Search
for
Sort by
Research 901–930 of 1000+
- Recent Formulation Advances of Mangiferin
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Steroid Hormones
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- Role of skin microbiome and exosomes in Hair regeneration and disorders in diseases like Alopecia, Acne: A comprehensive review
- The hair follicle as a neuro-immuno-endocrine organ: Implications in hair disorders and regenerative therapies
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Melanocytes in regenerative medicine applications and disease modeling
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Immunopathogenesis of Primary Cicatricial Alopecia
- Using platelet-rich plasma to treat hair loss and thinning
- Influence of substance-P on cultured sebocytes
- Peroxisome Proliferator Activated Receptors Gamma Serum levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case Control Study
- Editor's Choice
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Immune cell regulation of the hair cycle
- Cutaneous drug reactions
- Patched-assoziierte Tumoren: Modifikatorgene und Pathogenese
- Female hair loss
- B‐ RAF , naevi and melanoma: a complex relationship
- Skin diseases in consequence of endocrine alterations
- Acquired scalp alopecia. Part I: A review
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Differential impact of environmental factors on systemic and localized autoimmunity
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Excimer Light versus Combination of Tacrolimus and Excimer Light in the Treatment of Alopecia Areata
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib